Wilms tumor 1 impairs apoptotic clearance of fibroblasts in distal fibrotic lung lesions
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci188819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Harshavardhana H Ediga und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: WT1 Proteins, Apoptosis, Fibroblasts, Idiopathic Pulmonary Fibrosis. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disease characterized by impaired fibroblast clearance and excessive extracellular matrix (ECM) protein production. Wilms tumor 1 (WT1), a transcription factor, is selectively upregulated in IPF fibroblasts. However, the mechanisms by which WT1 contributes to fibroblast accumulation and ECM production remain unknown. Here, we investigated the heterogeneity of WT1-expressing mesenchymal cells using single-nucleus RNA-Seq of distal lung tissues from patients with IPF and control donors. WT1 was selectively upregulated in a subset of IPF fibroblasts that coexpressed several prosurvival and ECM genes. The results of both loss-of-function and gain-of-function studies were consistent with a role for WT1 as a positive regulator of prosurvival genes to impair apoptotic clearance and promote ECM production. Fibroblast-specific overexpression of WT1 augmented fibroproliferation, myofibroblast accumulation, and ECM production during bleomycin-induced pulmonary fibrosis in young and aged mice. Together, these findings suggest that targeting WT1 is a promising strategy for attenuating fibroblast expansion and ECM production during fibrogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- Gordian Biotechnology, South San Francisco, California, USA.
- Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Molecular Genetics Lab, Leibniz Institute on Aging - Fritz Lipmann Institute, Jena, Germany.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Ediga, H. H., Vemulapalli, C. P., Sontake, V., Patel, P. K., Miyazaki, H., Popov, D., Jensen, M. B., Jegga, A. G., Huang, S. K., Englert, C., Schedl, A., Gupta, N., McCormack, F. X., & Madala, S. K. (2025). Wilms tumor 1 impairs apoptotic clearance of fibroblasts in distal fibrotic lung lesions. Journal of Clinical Investigation. https://doi.org/10.1172/jci188819
Vancouver
Ediga HH, Vemulapalli CP, Sontake V, Patel PK, Miyazaki H, Popov D, et al. Wilms tumor 1 impairs apoptotic clearance of fibroblasts in distal fibrotic lung lesions. Journal of Clinical Investigation. 2025. doi:10.1172/jci188819
BibTeX
@article{Ediga2025,
author = {Ediga, Harshavardhana H and Vemulapalli, Chanukya P and Sontake, Vishwaraj and Patel, Pradeep K and Miyazaki, Hikaru and Popov, Dimitry and Jensen, Martin B and Jegga, Anil G and Huang, Steven K and Englert, Christoph and Schedl, Andreas and Gupta, Nishant and McCormack, Francis X and Madala, Satish K},
title = {Wilms tumor 1 impairs apoptotic clearance of fibroblasts in distal fibrotic lung lesions},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci188819}
}
EUVIMED